文献速递消化内镜消化道肿瘤与早癌

具有临床意义的锯齿状息肉检出率与结肠镜后结直肠癌风险:来自新罕布什尔州结肠镜登记处的数据

Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry.
PubMed 文献 · Gastrointest Endosc · 2022-03-08

研究利用新罕布什尔州结肠镜登记处数据,纳入128例在指数检查至少6个月后诊断结直肠癌的患者和142名内镜医师,分析内镜医师的临床意义锯齿状息肉检出率(CSSDR)与结肠镜后结直肠癌(PCCRC)风险的关系。结果显示,CSSDR为3%至<9%或≥9%的内镜医师,其PCCRC风险显著低于CSSDR<3%者。作者认为CSSDR可作为内镜医师的临床相关质量指标。

要点

  • 内镜医师CSSDR为3%至<9%时,PCCRC风险显著低于CSSDR<3%(HR 0.57)。
  • 内镜医师CSSDR≥9%时,PCCRC风险显著低于CSSDR<3%(HR 0.39)。
  • 研究首次证明较高CSSDR与较低PCCRC风险相关,支持CSSDR作为质量指标。

核心结论

  • 研究首次证明,由CSSDR较高的内镜医师完成的检查,其PCCRC风险较低。
  • CSSDR为9%及以上和3%至<9%者,PCCRC风险均显著低于CSSDR<3%者。
  • 这些数据验证CSSDR可作为内镜医师的临床相关质量指标。

研究设计与样本

  • 基于新罕布什尔州结肠镜登记处(NHCR)的数据,纳入至少有一次随访事件(结肠镜检查或通过链接新罕布什尔州癌症登记处识别的结直肠癌诊断)的患者。
  • 纳入128例在指数检查至少6个月后诊断结直肠癌的患者,队列包括142名内镜医师(其中92名消化内科医师)。
  • 排除在指数检查时或6个月内诊断结直肠癌、检查不完整或患有炎症性肠病的患者。
  • 暴露变量为内镜医师在指数结肠镜检查时的CSSDR。
  • 采用Cox回归分析CSSDR与PCCRC风险的关系,控制年龄、性别、指数检查发现、检查年份、结直肠肿瘤个人史和超过1次监测检查。

主要发现

  • PCCRC定义为指数检查后6至36个月、6至60个月或所有检查(6个月或更长)后诊断的结直肠癌。
  • 相对于CSSDR<3%的内镜医师,CSSDR为3%至<9%的内镜医师的PCCRC风险显著较低(HR 0.57;95%CI 0.39-0.83)。
  • 相对于CSSDR<3%的内镜医师,CSSDR≥9%的内镜医师的PCCRC风险显著较低(HR 0.39;95%CI 0.20-0.78)。

关键数值与推荐

  • CSSP定义为任何无蒂锯齿状息肉、传统锯齿状腺瘤、大的(≥1 cm)或近端增生性息肉>5 mm。
  • PCCRC风险在CSSDR 3%至<9%组相对于<3%组的HR为0.57(95%CI 0.39-0.83)。
  • PCCRC风险在CSSDR≥9%组相对于<3%组的HR为0.39(95%CI 0.20-0.78)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Higher adenoma detection rates reduce the risk of postcolonoscopy colorectal cancer (PCCRC). Clinically significant serrated polyps (CSSPs; defined as any sessile serrated polyp, traditional serrated adenoma, large [≥1 cm] or proximal hyperplastic polyp >5 mm) also lead to PCCRC, but there are no data on associated CSSP detection rates (CSSDRs). We used data from the New Hampshire Colonoscopy Registry (NHCR) to investigate the association between PCCRC risk and endoscopist CSSDR. METHODS: We included NHCR patients with 1 or more follow-up events: either a colonoscopy or a colorectal cancer (CRC) diagnosis identified through linkage with the New Hampshire State Cancer Registry. We defined our outcome, PCCRC, in 3 time periods: CRC diagnosed 6 to 36 months, 6 to 60 months, or all examinations (6 months or longer) after an index examination. We excluded patients with CRC diagnosed at or within 6 months of the index examination, with incomplete examinations, or with inflammatory bowel disease. The exposure variable was endoscopist CSSDR at the index colonoscopy. Cox regression was used to model the hazard of PCCRC on CSSDR controlling for age, sex, index findings, year of examination, personal history of colorectal neoplasia, and having more than 1 surveillance examination. RESULTS: One hundred twenty-eight patients with CRC diagnosed at least 6 months after their index examination were included. Our cohort included 142 endoscopists (92 gastroenterologists). We observed that the risk for PCCRC 6 months or longer after the index examination was significantly lower for examinations performed by endoscopists with CSSDRs of 3% to <9% (hazard ratio [HR], .57; 95% confidence interval [CI], .39-.83) or 9% or higher (HR, .39; 95% CI, .20-.78) relative to those with CSSDRs under 3%. CONCLUSIONS: Our study is the first to demonstrate a lower PCCRC risk after examinations performed by endoscopists with higher CSSDRs. Both CSSDRs of 9% and 3% to <9% had statistically lower risk of PCCRC than CSSDRs of <3%. These data validate CSSDR as a clinically relevant quality measure for endoscopists.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Anderson JC, Hisey W, Mackenzie TA, et al. Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2022. PMID: 35276209. doi:10.1016/j.gie.2022.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。